Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HB0025 |
Trade Name | |
Synonyms | HB-0025|HB 0025 |
Drug Descriptions |
HB0025 is a bispecific antibody comprised of a monoclonal antibody targeting CD274 (PD-L1) fused to extracellular domain 2 of VEGFR1 to target VEGF, which potentially inhibits tumor growth (PMID: 34925354). |
DrugClasses | PD-L1/PD-1 antibody 121 VEGF Antibody 12 |
CAS Registry Number | NA |
NCIT ID | C179665 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HB0025 | HB0025 | 0 | 1 |